Works matching IS 17762596 AND DT 2022 AND VI 17 AND IP 2
Results: 10
Correction to: Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Phase I Study of Glesatinib (MGCD265) in Combination with Erlotinib or Docetaxel in Patients with Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 125, doi. 10.1007/s11523-022-00875-0
- By:
- Publication type:
- Article
Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP).
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 167, doi. 10.1007/s11523-022-00874-1
- By:
- Publication type:
- Article
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 177, doi. 10.1007/s11523-022-00871-4
- By:
- Publication type:
- Article
Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 111, doi. 10.1007/s11523-022-00870-5
- By:
- Publication type:
- Article
The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 95, doi. 10.1007/s11523-022-00869-y
- By:
- Publication type:
- Article
Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 153, doi. 10.1007/s11523-022-00868-z
- By:
- Publication type:
- Article
Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 187, doi. 10.1007/s11523-022-00873-2
- By:
- Publication type:
- Article
Cabozantinib plus Nivolumab: A Review in Advanced Renal Cell Carcinoma.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 193, doi. 10.1007/s11523-022-00866-1
- By:
- Publication type:
- Article
Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin ± Trastuzumab in Advanced Solid Tumors.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 2, p. 141, doi. 10.1007/s11523-022-00867-0
- By:
- Publication type:
- Article